Pharmaceutical Commerce - December 2022

Click the title above for a link to open the Pharmaceutical Commerce December 2022 issue in an interactive PDF format.

Companies along the pharma value chain strive for carbon neutrality

Stakeholders are investing heavily in their ability to curate appropriate data sets and devise advanced data-analytics capabilities to harness real-world evidence (RWE) across the entire pharma lifecycle—from drug discovery and development through product launch and commercialization

Exploring the legislation's diverging requirements between regulatory agencies and global payers, and its impact on the commercial results of biopharma companies

How to make commercial AI actionable in the last mile, helping to better realize data science investment and improve customer engagement

How biopharma commercial teams can leverage machine learning techniques to improve targeting of HCPs and patients

How privacy and technology literacy can coexist behind a blockchain-based approach to patient data analytics and control

How artificial intelligence is improving the patient experience

No longer just a vision, the technology exists today to make an internet-level of scalability in pharma track and trace a reality